lactobacillus casei

lactobacillus casei is a probiotic bacterial species used as an orally administered live microbial therapeutic or supplement intended to modulate the intestinal microbiome and host immune-metabolic signaling. Across the provided public sources, it appears in preclinical and clinical contexts for metabolic disease, gastrointestinal inflammation, alcohol-related gut-brain effects, and other inflammatory conditions. Its proposed mechanism is not a single receptor-target interaction; rather, it acts through microbiome modulation, reinforcement of gut barrier function, suppression of pro-inflammatory cytokine signaling, and downstream effects on host metabolism and immune tone. The name is somewhat nonspecific in practice because some studies use unspecified L. casei preparations while others use a defined strain such as Lactobacillus casei strain Shirota, so annotations should be interpreted as applying to the species-level agent rather than a uniquely characterized commercial strain unless explicitly stated.

Other names

Lactobacillus caseiL. casei干酪乳杆菌